Insider sale
TAYSHA GENE THERAPIES, INC.
$147.8K
31.34K shares
What this filing means
HAQUE-AHMED RUMANA plans to sell 31.34K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $147.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0002086827-26-000006
31.34K
Shares to sell
$147.8K
Approx. market value
697.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
2/3/2026
697.00Total acquired697.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 697.00 | — |
| Total | 697.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.11K
Market value
$32.8K
1/26/2026
—Completed
Units to sell
23.53K
Market value
$111.8K
1/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
697.00
Market value
$3.3K
2/4/2026
Total
Units
31.34K
Value
$147.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 7.11K | $32.8K | — | Completed |
1/23/2026 | 23.53K | $111.8K | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 697.00 | $3.3K | Nasdaq | Planned |
| Total | 31.34K | $147.8K | ||